Skip to content

ResMed RMD Price / earnings

Price / earnings at other companies

Eli Lilly logo
Eli LillyLLY
32.5×-34.3×
Stryker logo
StrykerSYK
37.7×-12.0×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
17×+0.1×
Boston Scientific logo
Boston ScientificBSX
26.2×-47.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
55×-16.7×
Abbott logo
AbbottABT
28.4×+11.4×

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$27.02B-0.5%
Enterprise value$26.47B-2.0%
P/S4.9×-0.5×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Calculated from ResMed’s reported figures.

Based on the most recent quarter.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's price / earnings?
ResMed (RMD) reported price / earnings of 21.5× in Q1 2026.
How has ResMed's price / earnings changed year-over-year?
ResMed's price / earnings decreased by 14.0% year-over-year, from 25× to 21.5×.
What is the long-term trend for ResMed's price / earnings?
Over 4 years (2021 to 2025), ResMed's price / earnings has grown at a -15.6% compound annual growth rate (CAGR), from 218.6× to 110.9×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.